Dbct scheme

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Chemotherapy protocol with combination of chemotherapeutic agents listed below.

IndicationThis section has been translated automatically.

Melanoma, malignant; Merkel cell carcinoma.

ImplementationThis section has been translated automatically.

Therapy cycle with:
  • Dacarbazin 220 mg/m2 KO/day i.v., day 1-3.
  • BCNU 150 mg/m2 KO/day i.v., day 1 (2nd cycle).
  • Cisplatin 25 mg/m2 KO/day i.v., day 1-3.
  • Tamoxifen 2 times 10 mg/day p.o.
repetition every 3 weeks.

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer